|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61K 31/277 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/343 | (2006.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 31/366 | (2006.01) | ||
| A61K 31/22 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/453 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 2363130 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11164518.0 |
| Date of filing the European patent application | 2007-07-03 | |
| (97) | Date of publication of the European application | 2011-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-07 |
| (46) | Date of publication of the claims translation | 2014-08-25 |
| (30) | Number | Date | Country code |
| 06116625 | 2006-07-05 | EP |
| (72) |
Wollin, Stefan-Lutz, DE
Wohlsen, Andrea, DE
Braun, Clemens, DE
Marx, Degenhard, DE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | HMG-CoA reduktazės inhibitorių atorvastatino arba simvastatino derinys su fosfodiesterazės 4 inhibitoriumi, tokiu kaip roflumilastas, skirtas uždegiminių plaučių ligų gydymui |
| Combination of HMG-CoA reductase inhibitors atorvastatin or simvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast for the treatment of inflammatory pulmonary diseases |
| Payment date | Validity (years) | Amount | |
| 2019-06-19 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-07-03 |